Structure-Based Design of a Botulinum Neurotoxin With Triple Receptor Recognition

被引：1

作者：

Masuyer, Geoffrey ^{[1
,2
]}

Stenmark, Pal ^{[1
,2
]}

机构：

[1] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden

[2] ToxoTech AB, Stockholm, Sweden

来源：

TOXICON | 2024年 / 237卷

基金：

瑞典研究理事会;

关键词：

Drug design; Protein engineering; Structural biology;

D O I：

10.1016/j.toxicon.2024.107452

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：57 / 57

页数：1

共 50 条

[41] Structure-based design of agrochemicals
Walter, MW
NATURAL PRODUCT REPORTS, 2002, 19 (03) : 278 - 291
[42] Structure-based drug design
Kubinyi, H
CHIMICA OGGI-CHEMISTRY TODAY, 1998, 16 (10) : 17 - 22
[43] STRUCTURE-BASED DRUG DESIGN
MONTGOMERY, JA
NIWAS, S
CHEMTECH, 1993, 23 (11) : 30 - 37
[44] Structure-based drug design
Murcko, MA
Caron, PR
Charifson, PS
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 297 - 306
[45] STRUCTURE-BASED DRUG DESIGN
COLMAN, PM
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1994, 4 (06) : 868 - 874
[46] Structure-based design of non-hypertrophic apelin receptor modulator
Wang, Wei-Wei
Ji, Su-Yu
Zhang, Wenjia
Zhang, Junxia
Cai, Chenxi
Hu, Rubi
Zang, Shao-Kun
Miao, Luwei
Xu, Haomang
Chen, Li-Nan
Yang, Zongkuai
Guo, Jia
Qin, Jiao
Shen, Dan-Dan
Liang, Ping
Zhang, Yan
CELL, 2024, 187 (06) : 1460 - 1475.e20
[47] Structure-based drug design
Blundell, TL
NATURE, 1996, 384 (6604) : 23 - 26
[48] Structure-based drug design
Amzel, LM
CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (04) : 366 - 369
[49] Structure-based design of a superagonist ligand for the vitamin D nuclear receptor
Hourai, Shinji
Rodrigues, Luis Cezar
Antony, Pierre
Reina-San-Martin, Bernardo
Ciesielski, Fabrice
Magnier, Benjamin Claude
Schoonjans, Kristina
Mourino, Antonio
Rochel, Natacha
Moras, Dino
CHEMISTRY & BIOLOGY, 2008, 15 (04): : 383 - 392
[50] Structure-Based Drug Design for Dopamine D3 Receptor
Feng, Zhiwei
Hou, Tingjun
Li, Youyong
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2012, 15 (10) : 775 - 791

← 1 2 3 4 5 →